Non-specific stimulatory effects of mastoparan on pancreatic islet nucleoside diphosphokinase activity: dissociation from insulin secretion.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 7840804)

Published in Biochem Pharmacol on January 18, 1995

Authors

A Kowluru1, S E Seavey, M E Rabaglia, S A Metz

Author Affiliations

1: Department of Medicine, University of Wisconsin School of Medicine, Madison 53792.

Articles by these authors

Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci. Diabetes (2000) 1.97

Glucose- and GTP-dependent stimulation of the carboxyl methylation of CDC42 in rodent and human pancreatic islets and pure beta cells. Evidence for an essential role of GTP-binding proteins in nutrient-induced insulin secretion. J Clin Invest (1996) 1.35

Anti-inflammatory agents as inhibitors of prostaglandin synthesis in man. Med Clin North Am (1981) 1.18

Selective inhibitors of GTP synthesis impede exocytotic insulin release from intact rat islets. J Biol Chem (1992) 1.12

Modulation of insulin secretion from normal rat islets by inhibitors of the post-translational modifications of GTP-binding proteins. Biochem J (1993) 1.08

Evidence for differential roles of the Rho subfamily of GTP-binding proteins in glucose- and calcium-induced insulin secretion from pancreatic beta cells. Biochem Pharmacol (1997) 1.07

Carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting cells: evidence for functional consequences on enzyme activity and insulin secretion. Endocrinology (1996) 1.02

Altered arachidonic acid synthesis and lipid peroxidation in diabetes mellitus: possible roles in leukocyte dysfunction and other cellular defects. Med Hypotheses (1983) 1.00

Prolonged depletion of guanosine triphosphate induces death of insulin-secreting cells by apoptosis. Endocrinology (1998) 1.00

Characterization of nucleoside diphosphokinase activity in human and rodent pancreatic beta cells: evidence for its role in the formation of guanosine triphosphate, a permissive factor for nutrient-induced insulin secretion. Biochemistry (1994) 1.00

Stimulation by prostaglandin E2 of a high-affinity GTPase in the secretory granules of normal rat and human pancreatic islets. Biochem J (1994) 0.98

Subcellular localization and kinetic characterization of guanine nucleotide binding proteins in normal rat and human pancreatic islets and transformed beta cells. Biochim Biophys Acta (1994) 0.96

Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions. Cancer Epidemiol Biomarkers Prev (1999) 0.96

A novel regulatory mechanism for trimeric GTP-binding proteins in the membrane and secretory granule fractions of human and rodent beta cells. Biochem J (1996) 0.95

Sounding board. Prostaglandins, the glucoreceptor, and diabetes. N Engl J Med (1979) 0.95

Glucose increases the synthesis of lipoxygenase-mediated metabolites of arachidonic acid in intact rat islets. Proc Natl Acad Sci U S A (1985) 0.94

Glucose activates the carboxyl methylation of gamma subunits of trimeric GTP-binding proteins in pancreatic beta cells. Modulation in vivo by calcium, GTP, and pertussis toxin. J Clin Invest (1997) 0.94

Paradoxical inhibition of insulin secretion by glucose in human diabetes mellitus. J Clin Endocrinol Metab (1979) 0.93

Normal Akt/PKB with reduced PI3K activation in insulin-resistant mice. Am J Physiol Endocrinol Metab (2001) 0.92

Small elevations of glucose concentration redirect and amplify the synthesis of guanosine 5'-triphosphate in rat islets. J Clin Invest (1993) 0.92

Induction of defective insulin secretion and impaired glucose tolerance by clonidine. Selective stimulation of metabolic alpha-adrenergic pathways. Diabetes (1978) 0.92

p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells. Cell Death Differ (2004) 0.92

Prostaglandins as mediators of paraneoplastic syndromes: review and up-date. Metabolism (1981) 0.92

Plasma prostaglandin E in patients with cancer with and without hypercalcemia. J Clin Endocrinol Metab (1976) 0.92

Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1 alpha in endometriosis. Am J Obstet Gynecol (1981) 0.91

Lipoxygenation of arachidonic acid: a pivotal step in stimulus-secretion coupling in the pancreatic beta cell. Endocrinology (1982) 0.91

A phospholipase D-like mechanism in pancreatic islet cells: stimulation by calcium ionophore, phorbol ester and sodium fluoride. Biochem Biophys Res Commun (1989) 0.90

Characterization of prenylcysteine methyltransferase in insulin-secreting cells. Biochem J (1996) 0.89

Ceramide-activated protein phosphatase-2A activity in insulin-secreting cells. FEBS Lett (1997) 0.89

Inhibition of prostaglandin E synthesis augments glucose-induced insulin secretion is cultured pancreas. Diabetes (1981) 0.89

Rapid extraction of leukotrienes from biologic fluids and quantitation by high-performance liquid chromatography. J Chromatogr (1982) 0.89

Krukenberg carcinoma of the ovary with bone marrow involvement. Report of 2 cases and review of the literature. Obstet Gynecol (1980) 0.89

Is phospholipase A2 a "glucose sensor" responsible for the phasic pattern of insulin release? Prostaglandins (1984) 0.87

Use of a soluble tetrazolium compound to assay metabolic activation of intact beta cells. Metabolism (1998) 0.86

Phasic effects of glucose, phospholipase A2, and lysophospholipids on insulin secretion. Endocrinology (1987) 0.86

Lysophosphatidylinositol, but not lysophosphatidic acid, stimulates insulin release. A possible role for phospholipase A2 but not de novo synthesis of lysophospholipid in pancreatic islet function. Biochem Biophys Res Commun (1986) 0.86

Evaluation of nurses and genetic counselors as providers of education about breast cancer susceptibility testing. Oncol Nurs Forum (2000) 0.86

Effects on glucose-induced insulin secretion of lipoxygenase-derived metabolites of arachidonic acid. Diabetes (1984) 0.86

Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation. Cell Growth Differ (1998) 0.86

Regulation of guanine-nucleotide binding proteins in islet subcellular fractions by phospholipase-derived lipid mediators of insulin secretion. Biochim Biophys Acta (1994) 0.85

Phasic glucose-stimulated insulin secretion by neonatal rat pancreatic islet cells. Enhancement by sodium salicylate. Diabetes (1984) 0.84

Suppression of plasma catecholamines and flushing by clonidine in man. J Clin Endocrinol Metab (1978) 0.84

Unmasking of arachidonate-induced insulin release by removal of extracellular calcium. Arachidonic acid mobilizes cellular calcium in rat islets of Langerhans. Biochem Biophys Res Commun (1987) 0.83

Neuroendocrine modulation of calcitonin and parathyroid hormone in man. J Clin Endocrinol Metab (1978) 0.83

A defect late in stimulus-secretion coupling impairs insulin secretion in Goto-Kakizaki diabetic rats. Diabetes (1999) 0.83

Oxygenation products of arachidonic acid: third messengers for insulin release. J Allergy Clin Immunol (1984) 0.83

Peritoneal fluid volume in endometriosis. Fertil Steril (1980) 0.83

Evidence of a role for GTP in the potentiation of Ca(2+)-induced insulin secretion by glucose in intact rat islets. J Clin Invest (1995) 0.83

Role for GTP in glucose-induced phospholipase C activation in pancreatic islets. Am J Physiol (1996) 0.82

Lack of specificity of melittin as a probe for insulin release mediated by endogenous phospholipase A2 or lipoxygenase. Biochem Pharmacol (1986) 0.81

Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells. Diabetes (1996) 0.81

A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics. Metabolism (1981) 0.80

Improvement of insulin secretion in diabetics by a prostaglandin synthesis inhibitor. Adv Exp Med Biol (1979) 0.80

Prostaglandin synthesis inhibitors reverse alpha-adrenergic inhibition of acute insulin response to glucose. Am J Physiol (1980) 0.80

Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone. N Engl J Med (1977) 0.80

Putative roles for lysophospholipids as mediators and lipoxygenase-mediated metabolites of arachidonic acid as potentiators of stimulus-secretion coupling: dual mechanisms of p-hydroxymercuribenzoic acid-induced insulin release. J Pharmacol Exp Ther (1986) 0.79

Cyclosporin-induced inhibition of insulin release. Possible role of voltage-dependent calcium transport channels. Biochem Pharmacol (1988) 0.79

Lipoxygenase inhibitors reduce insulin secretion without impairing calcium mobilization. Endocrinology (1987) 0.79

Ether-linked lysophospholipids initiate insulin secretion. Lysophospholipids may mediate effects of phospholipase A2 activation on hormone release. Diabetes (1986) 0.79

A role for the lipoxygenase pathway of arachidonic acid metabolism in glucose- and glucagon-induced insulin secretion. Life Sci (1983) 0.79

Purine nucleotide- and sugar phosphate-induced inhibition of the carboxyl methylation and catalysis of protein phosphatase-2A in insulin-secreting cells: protection by divalent cations. Biosci Rep (1998) 0.79

p-Hydroxymercuribenzoic acid inhibits arachidonic acid esterification into two distinct pools and stimulates insulin release in intact rat islets. J Pharmacol Exp Ther (1986) 0.79

Feedback modulation of glucose-induced insulin secretion by arachidonic acid metabolites: possible molecular mechanisms and relevance to diabetes mellitus. Prostaglandins Med (1981) 0.79

Anticoagulation of autologous cord blood for neonatal resuscitation. Am J Obstet Gynecol (1982) 0.78

Prostaglandin E2 metabolite levels during diabetic ketoacidosis. Diabetes (1985) 0.78

Neuroendocrine tumours that secrete biologically active peptides and amines. Clin Endocrinol Metab (1977) 0.78

Applications and limitations of measurement of 15-keto,13,14-dihydro prostaglandin E2 in human blood by radioimmunoassay. Prostaglandins (1979) 0.78

Ectopic secretion of chorionic gonadotropin by a lung carcinoma. Pituitary gonadotropin and subunit secretion and prolonged chemotherapeutic remission. Am J Med (1978) 0.77

Immunolocalization of eicosanoid enzymes and growth factors in human myometrium and fetoplacental tissues in failed labor inductions. Obstet Gynecol (1996) 0.77

A role for prostaglandins as mediators of alpha-adrenergic inhibition of the acute insulin response to glucose. Adv Prostaglandin Thromboxane Res (1980) 0.77

A re-interpretation of lipoxygenase-dependent insulin release: which metabolites of arachidonic acid, or none? Life Sci (1986) 0.77

Biologic activity of ectopic parathyroid hormone. N Engl J Med (1977) 0.77

A classification of ectopic hormone-producing tumors. Ann N Y Acad Sci (1974) 0.77

Hypothesis: prostaglandins mediate defective glucose recognition in diabetes mellitus. Prostaglandins Med (1980) 0.77

Effects of inhibitors of guanine nucleotide synthesis on membrane potential and cytosolic free Ca2+ levels in insulin-secreting cells. Biochem Pharmacol (2000) 0.77

Sodium salicylate augments the plasma adrenocorticotropin and cortisol responses to insulin hypoglycemia in man. J Clin Endocrinol Metab (1982) 0.77

Metabolism of lysophospholipids in intact rat islets. The insulin secretagogue p-hydroxymercuribenzoic acid impairs lysophosphatidylcholine catabolism and permits its accumulation. Biochem J (1987) 0.76

Linoleic acid absorption in children with cystic fibrosis. J Pediatr Gastroenterol Nutr (1982) 0.76

Defects in transcription coupled repair interfere with expression of p90(MDM2) in response to ultraviolet light. Oncogene (2001) 0.76

Of mice and men (and rats): caveats in defining specific roles of GTP in the pancreatic islet. Biochem J (1997) 0.75

Letter: Ectopic hormones from tumors. Ann Intern Med (1975) 0.75

Preventive care for women--does the sex of the physician matter? N Engl J Med (1994) 0.75

Radioimmunoassay for 13,14-dihydro,15-keto-prostaglandin E2 in human plasma: applications and artifacts. Adv Prostaglandin Thromboxane Res (1980) 0.75

Effects of clonidine on hormone and substrate responses to hypoglycemia. Clin Pharmacol Ther (1980) 0.75

PGE, hypercalcemia, and subcutaneous fat necrosis. J Pediatr (1980) 0.75